{"id":"https://openalex.org/W2934448741","doi":"https://doi.org/10.1186/s12885-019-5407-9","title":"NUP98 \u2013 a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer","display_name":"NUP98 \u2013 a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer","publication_year":2019,"publication_date":"2019-04-01","ids":{"openalex":"https://openalex.org/W2934448741","doi":"https://doi.org/10.1186/s12885-019-5407-9","mag":"2934448741","pmid":"https://pubmed.ncbi.nlm.nih.gov/30935371","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6444590"},"language":"en","primary_location":{"id":"doi:10.1186/s12885-019-5407-9","doi":"https://doi.org/10.1186/s12885-019-5407-9","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12885-019-5407-9","pdf_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-019-5407-9","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-019-5407-9","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014851181","display_name":"Paul B. Mullan","orcid":"https://orcid.org/0000-0003-1479-7084","observed_orcids":["https://orcid.org/0000-0003-1479-7084"]},"institutions":[{"id":"https://openalex.org/I126231945","display_name":"Queen's University Belfast","ror":"https://ror.org/00hswnk62","country_code":"GB","type":"education","lineage":["https://openalex.org/I126231945"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paul B. Mullan","raw_affiliation_strings":["Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, BT9 7AE, Northern Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, BT9 7AE, Northern Ireland","institution_ids":["https://openalex.org/I126231945"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066381223","display_name":"Victoria Bingham","orcid":"https://orcid.org/0000-0002-2617-0345","observed_orcids":["https://orcid.org/0000-0002-2617-0345"]},"institutions":[{"id":"https://openalex.org/I126231945","display_name":"Queen's University Belfast","ror":"https://ror.org/00hswnk62","country_code":"GB","type":"education","lineage":["https://openalex.org/I126231945"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Victoria Bingham","raw_affiliation_strings":["Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, BT9 7AE, Northern Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, BT9 7AE, Northern Ireland","institution_ids":["https://openalex.org/I126231945"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079603792","display_name":"Paula Haddock","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126231945","display_name":"Queen's University Belfast","ror":"https://ror.org/00hswnk62","country_code":"GB","type":"education","lineage":["https://openalex.org/I126231945"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paula Haddock","raw_affiliation_strings":["School of Pharmacy, Queen's University Belfast, Belfast, BT9 7BL, Northern Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Queen's University Belfast, Belfast, BT9 7BL, Northern Ireland","institution_ids":["https://openalex.org/I126231945"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067880138","display_name":"Gareth W. Irwin","orcid":"https://orcid.org/0000-0002-2499-5896","observed_orcids":["https://orcid.org/0000-0002-2499-5896"]},"institutions":[{"id":"https://openalex.org/I126231945","display_name":"Queen's University Belfast","ror":"https://ror.org/00hswnk62","country_code":"GB","type":"education","lineage":["https://openalex.org/I126231945"]},{"id":"https://openalex.org/I4210092852","display_name":"Manchester University NHS Foundation Trust","ror":"https://ror.org/00he80998","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210092852"]},{"id":"https://openalex.org/I4210150798","display_name":"Wythenshawe Hospital","ror":"https://ror.org/05vpsdj37","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210092852","https://openalex.org/I4210150798"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gareth W. Irwin","raw_affiliation_strings":["Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, BT9 7AE, Northern Ireland","Nightingale Breast Centre, Wythenshawe Hospital, Manchester University Foundation Trust, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, BT9 7AE, Northern Ireland","institution_ids":["https://openalex.org/I126231945"]},{"raw_affiliation_string":"Nightingale Breast Centre, Wythenshawe Hospital, Manchester University Foundation Trust, Manchester, UK","institution_ids":["https://openalex.org/I4210092852","https://openalex.org/I4210150798"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110045612","display_name":"Elaine Williamson Kay","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142762351","display_name":"Royal College of Surgeons in Ireland","ror":"https://ror.org/01hxy9878","country_code":"IE","type":"education","lineage":["https://openalex.org/I142762351"]},{"id":"https://openalex.org/I2801846703","display_name":"Beaumont Hospital","ror":"https://ror.org/043mzjj67","country_code":"IE","type":"healthcare","lineage":["https://openalex.org/I2801846703"]}],"countries":["IE"],"is_corresponding":false,"raw_author_name":"Elaine Kay","raw_affiliation_strings":["Department of Surgery, Beaumont Hospital and Royal College of Surgeons in Ireland, Dublin, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, Beaumont Hospital and Royal College of Surgeons in Ireland, Dublin, Ireland","institution_ids":["https://openalex.org/I142762351","https://openalex.org/I2801846703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048652049","display_name":"Stephen McQuaid","orcid":"https://orcid.org/0000-0003-0794-8569","observed_orcids":["https://orcid.org/0000-0003-0794-8569"]},"institutions":[{"id":"https://openalex.org/I126231945","display_name":"Queen's University Belfast","ror":"https://ror.org/00hswnk62","country_code":"GB","type":"education","lineage":["https://openalex.org/I126231945"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stephen McQuaid","raw_affiliation_strings":["Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, BT9 7AE, Northern Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, BT9 7AE, Northern Ireland","institution_ids":["https://openalex.org/I126231945"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034722527","display_name":"Niamh E. Buckley","orcid":"https://orcid.org/0000-0001-9326-8513","observed_orcids":["https://orcid.org/0000-0001-9326-8513"]},"institutions":[{"id":"https://openalex.org/I126231945","display_name":"Queen's University Belfast","ror":"https://ror.org/00hswnk62","country_code":"GB","type":"education","lineage":["https://openalex.org/I126231945"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Niamh E. Buckley","raw_affiliation_strings":["School of Pharmacy, Queen's University Belfast, Belfast, BT9 7BL, Northern Ireland. n.obrien@qub.ac.uk","School of Pharmacy, Queen's University Belfast, Belfast, BT9 7BL, Northern Ireland"],"raw_orcid":"https://orcid.org/0000-0001-9326-8513","affiliations":[{"raw_affiliation_string":"School of Pharmacy, Queen's University Belfast, Belfast, BT9 7BL, Northern Ireland. n.obrien@qub.ac.uk","institution_ids":["https://openalex.org/I126231945"]},{"raw_affiliation_string":"School of Pharmacy, Queen's University Belfast, Belfast, BT9 7BL, Northern Ireland","institution_ids":["https://openalex.org/I126231945"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5034722527"],"corresponding_institution_ids":["https://openalex.org/I126231945"],"apc_list":{"value":2390,"currency":"USD","value_usd":2390},"apc_paid":{"value":2390,"currency":"USD","value_usd":2390},"fwci":0.7098,"has_fulltext":true,"cited_by_count":17,"citation_normalized_percentile":{"value":0.58523484,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"19","issue":"1","first_page":"236","last_page":"236"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11134","display_name":"Breast Lesions and Carcinomas","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nup98","display_name":"NUP98","score":0.9959999918937683},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/anthracycline-based-chemotherapy","display_name":"anthracycline chemotherapy","score":0.9869999885559082},{"id":"https://openalex.org/keywords/chemotherapy-response-prediction","display_name":"chemotherapy response prediction","score":0.859000027179718},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.9480000138282776},{"id":"https://openalex.org/keywords/taxane-based-chemotherapy","display_name":"taxane-based chemotherapy","score":0.8080000281333923},{"id":"https://openalex.org/keywords/pathological-response","display_name":"pathological response","score":0.5370000004768372},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6000000238418579},{"id":"https://openalex.org/keywords/breast-cancer-subtypes","display_name":"breast cancer subtypes","score":0.49799999594688416}],"concepts":[{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.8296102285385132},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8078874349594116},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7920098304748535},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.7310867309570312},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.6972754597663879},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.685804009437561},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6323180198669434},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.6186427474021912},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.5788332223892212},{"id":"https://openalex.org/C2780140570","wikidata":"https://www.wikidata.org/wiki/Q3545481","display_name":"Surgical oncology","level":2,"score":0.5774625539779663},{"id":"https://openalex.org/C193270364","wikidata":"https://www.wikidata.org/wiki/Q17141925","display_name":"Tissue microarray","level":3,"score":0.4741346836090088},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4506441056728363},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08176830410957336},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001952","descriptor_name":"Bridged-Ring Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001952","descriptor_name":"Bridged-Ring Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018943","descriptor_name":"Anthracyclines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018943","descriptor_name":"Anthracyclines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D028861","descriptor_name":"Nuclear Pore Complex Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1186/s12885-019-5407-9","doi":"https://doi.org/10.1186/s12885-019-5407-9","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12885-019-5407-9","pdf_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-019-5407-9","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6444590","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6444590","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"Text"},{"id":"pmid:30935371","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30935371","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC cancer","raw_type":"Journal Article"},{"id":"pmh:oai:pure.qub.ac.uk/portal:openaire/d934dca1-c00c-41a5-89d6-34297d522311","doi":null,"is_oa":true,"landing_page_url":"https://pure.qub.ac.uk/en/publications/d934dca1-c00c-41a5-89d6-34297d522311","pdf_url":"https://pureadmin.qub.ac.uk/ws/files/167038769/s12885_019_5407_9.pdf","source":{"id":"https://openalex.org/S4306402319","display_name":"Research Portal (Queen's University Belfast)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I126231945","host_organization_name":"Queen's University Belfast","host_organization_lineage":["https://openalex.org/I126231945"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Mullan, P B, Bingham, V, Haddock, P, Irwin, G W, Kay, E, McQuaid, S & Buckley, N E 2019, 'NUP98 \u2013 a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer', BMC Cancer, vol. 19, 236. https://doi.org/10.1186/s12885-019-5407-9","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:4531eab64b0f409585612c4bdac7b40f","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/4531eab64b0f409585612c4bdac7b40f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMC Cancer, Vol 19, Iss 1, Pp 1-13 (2019)","raw_type":"article"},{"id":"pmh:oai:epubs.rcsi.ie:surgart-1053","doi":null,"is_oa":true,"landing_page_url":"https://epubs.rcsi.ie/surgart/51","pdf_url":null,"source":null,"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Surgery Articles","raw_type":"text"},{"id":"pmh:oai:figshare.com:article/10800110","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/NUP98_-_a_novel_predictor_of_response_to_anthracycline-based_chemotherapy_in_triple_negative_breast_cancer_/10800110","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1186/s12885-019-5407-9","doi":"https://doi.org/10.1186/s12885-019-5407-9","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12885-019-5407-9","pdf_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-019-5407-9","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G2914773724","display_name":null,"funder_award_id":"SPI/5151/15","funder_id":"https://openalex.org/F4320320853","funder_display_name":"Public Health Agency"}],"funders":[{"id":"https://openalex.org/F4320315985","display_name":"Friends of the Cancer Centre","ror":"https://ror.org/00pngf587"},{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"},{"id":"https://openalex.org/F4320320853","display_name":"Public Health Agency","ror":"https://ror.org/03ek62e72"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2934448741.pdf","grobid_xml":"https://content.openalex.org/works/W2934448741.grobid-xml"},"referenced_works_count":44,"referenced_works":["https://openalex.org/W169584480","https://openalex.org/W1558366281","https://openalex.org/W1872971604","https://openalex.org/W1972769296","https://openalex.org/W1983135362","https://openalex.org/W1983914017","https://openalex.org/W1994487648","https://openalex.org/W1999389174","https://openalex.org/W2018486347","https://openalex.org/W2020016182","https://openalex.org/W2021026930","https://openalex.org/W2022253964","https://openalex.org/W2041321380","https://openalex.org/W2049556442","https://openalex.org/W2052009094","https://openalex.org/W2054555589","https://openalex.org/W2066239225","https://openalex.org/W2069998288","https://openalex.org/W2070476377","https://openalex.org/W2071036685","https://openalex.org/W2081894694","https://openalex.org/W2095744767","https://openalex.org/W2098686783","https://openalex.org/W2117546979","https://openalex.org/W2118126404","https://openalex.org/W2118605519","https://openalex.org/W2120742047","https://openalex.org/W2130333852","https://openalex.org/W2131604549","https://openalex.org/W2147701024","https://openalex.org/W2150671673","https://openalex.org/W2151184924","https://openalex.org/W2156510716","https://openalex.org/W2170602872","https://openalex.org/W2277909638","https://openalex.org/W2289044916","https://openalex.org/W2402636472","https://openalex.org/W2496738621","https://openalex.org/W2509809130","https://openalex.org/W2520938304","https://openalex.org/W2531294657","https://openalex.org/W2734718161","https://openalex.org/W2807015550","https://openalex.org/W4294541781"],"related_works":["https://openalex.org/W6902463812","https://openalex.org/W6977181291","https://openalex.org/W6958649524","https://openalex.org/W6902524484","https://openalex.org/W2170943405","https://openalex.org/W4362596982","https://openalex.org/W2267756227","https://openalex.org/W3100765884","https://openalex.org/W2169919433","https://openalex.org/W7135831549"],"abstract_inverted_index":{"BACKGROUND:":[0],"Triple":[1],"Negative":[2],"breast":[3,12,124,172],"cancer":[4,13,173],"(TNBC)":[5],"is":[6,143,247],"a":[7,42,54,61,83,122,218,248],"poor":[8,147],"outcome":[9,148],"subgroup":[10],"of":[11,19,21,44,49,57,63,256],"defined":[14],"based":[15,196,228],"on":[16],"the":[17,179,199,253],"absence":[18],"expression":[20,107,156,165],"ER\u03b1":[22],"and":[23,25,37,77,98,157,203],"PR":[24],"HER2":[26],"amplification.":[27],"These":[28],"hard":[29],"to":[30,69,91,96,130,191,194,226,234,242,244],"treat":[31],"cancers":[32],"lack":[33,89,100],"targeted":[34],"treatment":[35,102],"options":[36],"are":[38,239],"therefore":[39],"treated":[40,210],"with":[41,53,127,146,166,211],"standard":[43],"care":[45],"(SoC)":[46],"generic":[47],"cocktail":[48],"DNA":[50],"damaging":[51],"chemotherapy,":[52],"wide":[55],"range":[56],"clinical":[58,75],"responses.":[59],"While":[60,161],"subset":[62],"TNBC":[64,150],"patients":[65,94,209,237],"respond":[66,243],"very":[67],"well":[68,120],"this":[70],"treatment,":[71],"others":[72],"receive":[73],"no":[74],"benefit":[76],"die":[78],"from":[79],"their":[80],"disease":[81],"within":[82],"short":[84],"time":[85],"period.":[86],"We":[87,137,215],"currently":[88],"biomarkers":[90],"prospectively":[92,235],"identify":[93,236],"likely":[95,241],"relapse":[97],"we":[99],"alternate":[101],"options.":[103],"METHODS:":[104],"NUP98":[105,142,164,202],"protein":[106,159],"was":[108,134,205],"investigated":[109],"in":[110,149,171,178,187,208,230,251],"patient":[111,151],"samples":[112,152],"using":[113],"two":[114],"independent":[115],"tissue":[116],"microarrays":[117],"(TMAs),":[118],"as":[119,121,198],"normal":[123],"TMA.":[125],"Correlation":[126],"pathological":[128],"response":[129,204,225],"various":[131],"chemotherapy":[132,229,246],"regimens":[133,197],"investigated.":[135],"RESULTS:":[136],"have":[138,216],"shown":[139],"that":[140,222],"high":[141],"significantly":[144],"associated":[145],"both":[153],"by":[154],"gene":[155],"IHC-based":[158],"analysis.":[160],"trends":[162],"linking":[163],"poorer":[167],"outcomes":[168],"were":[169,185],"observed":[170,186,207],"overall":[174,254],"(and":[175],"more":[176],"specifically":[177],"LuminalB":[180],"Her2-":[181],"subgroup),":[182],"significant":[183],"correlations":[184],"TNBC.":[188,231],"This":[189],"appeared":[190],"be":[192],"specific":[193],"anthracycline":[195,227],"association":[200],"between":[201],"not":[206],"taxane-based":[212],"chemotherapy.":[213],"CONCLUSIONS:":[214],"identified":[217],"novel":[219],"biomarker,":[220],"NUP98,":[221],"can":[223],"predict":[224],"The":[232],"ability":[233],"who":[238],"less":[240],"SoC":[245],"vital":[249],"step":[250],"improving":[252],"survival":[255],"these":[257],"patients.":[258]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-04-11T00:00:00"}